Asset Allocation

As of October 31, 2025.
Type % Net
Cash 0.34%
Stock 64.06%
Bond 34.20%
Convertible 0.00%
Preferred 0.00%
Other 1.40%
View Asset Allocation
Start Trial

Market Capitalization

As of October 31, 2025
Large 62.65%
Mid 24.93%
Small 12.43%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 97.44%    % Emerging Markets: 0.28%    % Unidentified Markets: 2.28%

Americas 89.89%
89.88%
Canada 0.05%
United States 89.83%
0.00%
As of October 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 7.67%
United Kingdom 1.97%
5.33%
France 0.47%
Ireland 1.84%
Netherlands 0.97%
Spain 0.96%
Switzerland 0.56%
0.00%
0.37%
Israel 0.10%
Qatar 0.06%
Saudi Arabia 0.20%
Greater Asia 0.16%
Japan 0.00%
0.16%
Australia 0.16%
0.00%
0.00%
Unidentified Region 2.28%

Bond Credit Quality Exposure

AAA 3.83%
AA 63.94%
A 13.21%
BBB 16.24%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 2.78%
Short Term 0.00%
As of October 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
27.81%
Materials
0.81%
Consumer Discretionary
7.24%
Financials
17.55%
Real Estate
2.20%
Sensitive
55.20%
Communication Services
6.66%
Energy
3.96%
Industrials
10.54%
Information Technology
34.04%
Defensive
17.00%
Consumer Staples
2.53%
Health Care
13.08%
Utilities
1.40%
Not Classified
0.00%
Non Classified Equity
0.00%
Not Classified - Non Equity
0.00%
As of October 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of October 31, 2025
Type % Net
Government 62.74%
Corporate 28.78%
Securitized 6.35%
Municipal 1.78%
Other 0.36%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.31%
Less than 1 Year
0.31%
Intermediate
68.86%
1 to 3 Years
19.93%
3 to 5 Years
29.52%
5 to 10 Years
19.41%
Long Term
30.83%
10 to 20 Years
17.06%
20 to 30 Years
12.67%
Over 30 Years
1.10%
Other
0.00%
As of October 31, 2025
View Bond Maturity Exposure
Start Trial